Amdocs Limited DOX
43.66 USD -18.77 (-30.07%)
At closeNov 4, 2026, 5:04 PM EST
43.66 0.00 0.00%
After hours · Nov 4, 5:04 PM ET
41.44 Day range 46.39
41.44 52-week range 85.63
- YTD
- -45.77%
- 1 year
- -47.71%
Analyst view
Price target (mean) 73.00 +67.2% upside
Now 43.66
- Target (low)
- 46.00
- Target (mean)
- 73.00
- Target (high)
- 105.00
Ratings (0m) 6 3 buy · 3 hold · 0 sell
- Strong buy0
- Buy3
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.62 | 1.30 – 1.96 | 1.81 | -10.6% | 1.05B | -9.3% | 4 |
| Next quarter | 1.66 | 1.32 – 2.01 | 1.78 | -6.9% | 1.09B | -7.0% | 4 |
| Current year | 7.20 | 5.34 – 8.29 | 7.41 | -2.9% | 4.49B | -4.3% | 6 |
| Next year | 9.19 | 9.19 – 9.19 | 7.20 | +27.7% | 4.57B | +1.7% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 4, 2026 | Stifel | Maintained | Buy | Buy |
| Nov 4, 2026 | Oppenheimer | Downgrade | Outperform | Perform |
| Jun 29, 2026 | Keybanc | Initiated | — | Sector Weight |
| May 14, 2026 | Stifel | Maintained | Buy | Buy |
| Feb 5, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 4, 2026 | Stifel | Maintained | Buy | Buy |
| Nov 13, 2025 | Wolfe Research | Downgrade | Outperform | Peer Perform |
| Nov 12, 2025 | Stifel | Maintained | Buy | Buy |
| Nov 12, 2025 | B of A Securities | Maintained | Buy | Buy |
| Jul 8, 2025 | Wolfe Research | Initiated | — | Outperform |
| Nov 14, 2024 | Barclays | Maintained | Overweight | Overweight |
| Nov 13, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 2, 2024 | Stifel | Initiated | — | Buy |
| May 9, 2024 | Citigroup | Maintained | Buy | Buy |
| May 9, 2024 | Baird | Maintained | Neutral | Neutral |
| Feb 8, 2024 | Barclays | Maintained | Overweight | Overweight |
| Jan 17, 2024 | Citigroup | Maintained | Buy | Buy |
| Dec 1, 2023 | Jefferies | Initiated | — | Buy |
| Aug 3, 2023 | Oppenheimer | Maintained | Outperform | Outperform |
| May 16, 2023 | Barclays | Upgrade | Equal-Weight | Overweight |
| May 11, 2023 | Oppenheimer | Reiterated | Outperform | Outperform |
| Feb 2, 2023 | Baird | Maintained | — | Neutral |
| Feb 1, 2023 | Oppenheimer | Maintained | — | Outperform |
| Nov 9, 2022 | Citigroup | Maintained | — | Buy |
| Aug 4, 2022 | Barclays | Maintained | — | Equal-Weight |
| Aug 4, 2022 | Citigroup | Maintained | — | Buy |
| May 12, 2022 | Citigroup | Maintained | — | Buy |
| Dec 14, 2021 | JP Morgan | Downgrade | Overweight | Neutral |
| Aug 5, 2021 | Oppenheimer | Maintained | — | Outperform |
| Nov 11, 2020 | JP Morgan | Upgrade | Neutral | Overweight |